Julian Bowen Consort Dining Table, Honey, Height: 77, Width: 92, Depth: 92cm

Product Information

Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006; 144(5):364-367. [6] Open Science Collaboration. Estimating the reproducibility of psychological science. Science. 2015;349(6251):aac4716. If treatments are given sequentially will baseline information be recorded at the time of randomisation or at the time of treatment administration? Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ 2004; 328(7441):702-708. [1] Knottnerus JA, Tugwell P. The standards for reporting of diagnostic accuracy. J Clin Epidemiol 2003;56:1118e27

CONSORT CHECKLIST - JAMA Network

Riley W. New NIH Clinical Trials Policies: Implications for Behavioral and Social Science Researchers. 2016; https://obssr.od.nih.gov/new-nih-clinical-trials-policies-implications-for-behavioral-and-social-science-researchers/. Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada. Vohra S, Shamseer L, Sampson M, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015 statement. BMJ. 2015;350:h1738. Create a traditional farmhouse look in your home with the Consort Table. Constructed from solid Malaysian Hardwood in a honey pine lacquer finish allows this table to match almost anything, or simply match with the Consort dining chairs! This space-saving table folds into a half-moon shape, practical for those with a small kitchen. Due to the extensive range of wood types we supply, our Furniture will sometimes come with specific care instructions. Please read these carefully and adhere to these instructions to get the most out of your furniture.Gottfredson D, Cook T, Gardner F, et al. Standards of evidence for efficacy, effectiveness, and scale-up research in prevention science: next generation. Prev Sci. 2015;16(7):893–926. Since the revision in 2001, the evidence base to inform CONSORT has grown considerably; empirical data highlighting new concerns regarding the reporting of randomized trials. Therefore, a third CONSORT Group meeting was held in 2007, resulting in publication of a newly revised CONSORT Statement [1] and explanatory document [2] in 2010. Users of the guideline are strongly recommended to refer to the most up-to-date version while writing or interpreting reports of clinical trials. Montgomery P, Grant S, Mayo-Wilson E, et al. Reporting randomised trials of social and psychological interventions: The CONSORT-SPI 2017 Extension. TRLS-D-18-00052. In addition to financial interests, it is important that authors declare any other potential interests that may be perceived to influence the design, conduct, analysis, or reporting of the trial following established criteria [ 109]. Examples include allegiance to or professional training in evaluated interventions. Authors should err on the side of caution in declaring potential interests. If authors do not have any financial, professional, personal, or other potential interests to declare, they should declare this explicitly. Important information: stakeholder involvement CONSORT-SPI new item – Item 26a: any involvement of the intervention developer in the design, conduct, analysis, or reporting of the trial Contextualisation guidance for using the CONSORT guideline to report deprescribing trials has been developed:

CONSORT-SPI 2018 Explanation and Elaboration: guidance for CONSORT-SPI 2018 Explanation and Elaboration: guidance for

Moore G, Audrey S, Barker M, et al. Process evaluation in complex public health intervention studies: the need for guidance. J Epidemiol Community Health. 2013;68(2):101–2. Betz CL. Adoption of CONSORT statements for randomized control trials published in the Journal of Pediatric Nursing. J Pediatr Nurs. 2011;26(3):177-8. PMID: 21601140 For each group, the numbers of participants who were randomly assigned received intended treatment and were analyzed for the primary outcome

The CONSORT 2010 Statement: explanation and elaboration

Chalmers I. Trying to do more good than harm in policy and practice: the role of rigorous, transparent, up-to-date evaluations. Ann Am Acad Polit Soc Sci. 2003;589(22):22–40. CONSORT Equity: Welch VA, Norheim OF, Jull J, Cookson R, Sommerfelt H, Tugwell P; CONSORT-Equity and Boston Equity Symposium. CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials. BMJ. 2017;359:j5085. PMID: 29170161

Consort-Statement Consort-Statement

CONSORT Herbal: Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C, for the CONSORT Group. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT Statement. Ann Intern Med. 2006;144(5):364-367. PMID: 16520478The main CONSORT Statement is based on the "standard" two-group parallel design. Extensions of the CONSORT Statement have been developed to give additional guidance for randomized trials with specific designs (e.g., cluster randomized trials, [3] noninferiority and equivalence trials, [4] pragmatic trials, [5]), data (e.g., harms, [6] abstracts [7]), and various types of intervention (e.g., herbals, [8] non-pharmacologic treatments, [9] acupuncture [10]). A number of guidelines have been designed to complement CONSORT, including TIDieR (encouraging adequate descriptions of interventions) [11] and TIDieR-Placebo (encouraging adequate descriptions of placebo or sham controls). [12] This list is by no means exhaustive, and work is ongoing. Moher D, Hopewell S, Schultz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. Fletcher A, Jamal F, Moore G, Evans RE, Murphy S, Bonell C. Realist complex intervention science: applying realist principles across all phases of the Medical Research Council framework for developing and evaluating complex interventions. Evaluation. 2016;22(3):286–303. In many individually randomised trials, staff who generate and conceal the random sequence are different from the staff involved in implementing the sequence. This can prevent tampering or subversion [ 48]. Other procedures may be used to ensure true randomisation in trials in which participants (e.g. groups, places) are recruited and then randomised at the same time. Authors should indicate who carried out each procedure (i.e. generating the random sequence, enrolling participants, and assigning participants to interventions) and the methods used to protect the sequence. Methods: awareness of assignment Item 11a: who was aware after assignment to interventions (for example, participants, providers, those assessing outcomes), and how any masking was done If you’re looking to add some extra workspace or storage to your kitchen - a console table might be just the thing. The table will provide extra bench space giving you more room to work; a perfect solution for the smaller kitchen. Karate chopping the cucumbers, tomatoes, onions, and the likes for your mise en place have never been easier. And if you get yourself a table with storage, you can always have knives, bowls, and cutting boards close at hand.

CONSORT 2010 statement: extension to randomised crossover

Bower P, Brueton V, Gamble C, et al. Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities. Trials. 2014;15(1):399. To develop harmonized, evidence- and consensus-based standards for reporting outcomes in clinical trial reports through integration with the Consolidated Standards of Reporting Trials (CONSORT) 2010 statement. Completely defined pre-specified primary and secondary outcome measures, including how and when they were assessed Example 1—“A comparison of anterio Michie S, Fixsen D, Grimshaw J, Eccles M. Specifying and reporting complex behaviour change interventions: the need for a scientific method. Implement Sci. 2009;4:40.Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials. gov results database—update and key issues. N Engl J Med. 2011;364(9):852–60. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials . Ann Intern Med 2001; 134(8):657-662. [11] Concannon TW, Fuster M, Saunders T, et al. A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J Gen Intern Med. 2014;29(12):1692–701. Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.